Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.
Basile, Umberto; Gragnani, Laura; Piluso, Alessia; Gulli, Francesca; Urraro, Teresa; Dell'Abate, Maria T; Torti, Eleonora; Stasi, Cristina; Monti, Monica; Rapaccini, Gian Ludovico; Zignego, Anna Linda.
; 35(9): 2100-7, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25800731
Idiopathic Nonviral Cryoglobulinemia Treated Successfully With Rituximab.
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.
Decline of cellular activation in non-B cells after rituximab treatment in hepatitis C-associated mixed cryoglobulinemia vasculitis.
Cryoglobulinemic vasculitis with primary Sjögren's syndrome: A case report.
Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach.
Pediatric cryoglobulinemic vasculitis successfully managed with rituximab.
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.
Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.